SSG
AGN

Summit Securities Group’s Allergan plc AGN Stock Holding History

Summit Securities Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,400
Closed -$1.02M – 531
2019
Q4 		$1.03M Buy
+5,400
New +$974K 0.08% 207
2017
Q2 		– Sell
-8,680
Closed -$2.07M – 401
2017
Q1 		$2.07M Buy
+8,680
New +$2.02M 0.6% 38
2015
Q2 		– Sell
-131
Closed -$39K – 623
2015
Q1 		$39K Buy
+131
New +$37.3K 0.03% 218
2014
Q1 		– Sell
-480
Closed -$81K – 631
2013
Q4 		$81K Buy
+480
New +$75K 0.01% 245

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Summit Securities Group's AGN Position: Q1 2020 in Review

Summit Securities Group sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 5,400 shares — an estimated $1.02M sold.

Summit Securities Group first reported a position in AGN in Q4 2013 and held it in 4 quarters. The position peaked at $2.07M in Q1 2017. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Summit Securities Group reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Summit Securities Group sold 5,400 Allergan plc shares in Q1 2020, an estimated $1.02M.
  • Summit Securities Group first reported a position in Allergan plc in Q4 2013 and held it in 4 quarters.
  • Summit Securities Group's Allergan plc position peaked at $2.07M in Q1 2017.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Summit Securities Group's 13F filing for Q1 2020, filed 28 Apr 2020.